Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study.

Peter A LeWittGlenn T StebbinsKenneth Vielsted ChristensenRiswanto TanAnél PretoriusMikael Thomsen

Published in: Movement disorders : official journal of the Movement Disorder Society (2024)

In this proof-of-concept study, addition of buspirone/zolmitriptan to the patients' PD medication regimen significantly reduced dyskinesia severity without worsening motor function. © 2024 International Parkinson and Movement Disorder Society.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
healthcare
patient reported outcomes
patient reported
drug induced